Sonya Cyr

688 citations

31 papers · 494 indexed · h-index 15

Impact in

Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 5%
- Dermatology and Skin Diseases

Papers in

Dermatology 18
- Dermatology and Skin Diseases 18
Immunology and Allergy 11
- Food Allergy and Anaphylaxis Research 8
- Allergic Rhinitis and Sensitization 6

Co-authors: David S. Burt George H. Lowell Taff Jones Brian J. Ward Sophie Chabot Martin Plante Robert A. McDonald Kazuhiko Arima
Journals: Vaccine (8 papers)Journal of Allergy and Clinical Immunology (5 papers)Dermatology and Therapy (3 papers)Pediatric Dermatology (3 papers)British Journal of Dermatology (3 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Sonya Cyr

26 papers receiving 486 citations

Peers

Countries citing papers authored by Sonya Cyr

Since Specialization

Citations

This map shows the geographic impact of Sonya Cyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonya Cyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonya Cyr more than expected).

Fields of papers citing papers by Sonya Cyr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonya Cyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonya Cyr. The network helps show where Sonya Cyr may publish in the future.

Co-authors

The 25 scholars most cited alongside Sonya Cyr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sonya Cyr Line = papers co-authored together Sonya Cyr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dupilumab Efficacy In Pooled LIBERTY-CSU CUPID Study A And Study C Regardless Of Baseline Serum Total IgE Levels Journal of Allergy and Clinical Immunology ·Chang XuHong, (unknown), Xuanrui Li, Søs Frandsen, Kieran Basavaraja, Marina A. Stepkina, Yuqun Meng, Tayler Gonzalez, Sonya Cyr, (unknown), Allen Radin, Melanie Makhija	2026	0
2	Growth Analysis in Children Aged 6 to 11 Years and Adolescents Aged 12 to 17 Years With Moderate-To-Severe Atopic Dermatitis and Impact of 16 Weeks of Dupilumab Treatment on Height Journal of Allergy and Clinical Immunology ·Alan D. Irvine, Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Lisa A. Beck, Zhen Chen, C. Peralta, Zamiatina Mp, Akira Ikeuti, Sonya Cyr	2025	2
3	Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients Dermatology and Therapy ·Yael A. Leshem, Clara Weil, William W. Busse, Lisa Beck, Gabriel Chodick, Sonya Cyr, 裕治松戸, Daiana Fanesi	2025	0
4	64623 Dupilumab Treatment Significantly Reduces Age-Dependent Total IgE Levels in Young Children With Atopic Dermatitis Journal of the American Academy of Dermatology ·Lisa A. Beck, Amy S. Paller, Elaine C. Siegfried, Lawrence F. Eichenfield, Alan D. Irvine, Eric L. Simpson, Eulàlia Baselga, Peter Lio, Ana B. Rossi, Ho Bang Kim, Sonya Cyr	2025	0
5	A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis Pediatric Dermatology ·Elaine C. Siegfried, Lara Wine Lee, Jonathan M. Spergel, Randy Prescilla, G. Agolini, Anna Coleman, Ashish Bansal, Sonya Cyr, Brad Shumel	2024	9
6	Low Infection Rates With Long‐Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open‐Label Extension Study Pediatric Dermatology ·Amy S. Paller, Michele Ramien, Michael J. Cork, Eric L. Simpson, Lara Wine Lee, Lawrence F. Eichenfield, Faisal A. Khokhar, Anna Coleman, S. Liang, Zhen Chen, Zamiatina Mp, Sonya Cyr	2024	0
7	Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis Pediatric Drugs ·Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Peter D. Arkwright, Lawrence F. Eichenfield, Michele Ramien, Faisal A. Khokhar, Zhen Chen, Annie Zhang, Sonya Cyr	2024	3
8	Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial American Journal of Clinical Dermatology ·Elaine C. Siegfried, Michael J. Cork, Norito Katoh, Haixin Zhang, Chien‐Chia Chuang, Zibo maternai, Ana B. Rossi, Sonya Cyr, Annie Zhang	2023	8
9	P93 Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers British Journal of Dermatology ·Alan D. Irvine, Amy S. Paller, Julie Horowitz, Rama Islam, Sarah Hatsell, Hannah Seidler, Robert W. McDonald, Siv Strömquist, Tingting Tian, Sonya Cyr	2023	1
10	Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis Dermatology and Therapy ·El‐Bdaoui Haddad, Sonya Cyr, Kazuhiko Arima, Robert A. McDonald, Noah A. Levit, Frank O. Nestlé	2022	47
11	No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab Advances in Therapy ·Andrew Blauvelt, Andreas Wollenberg, Lawrence F. Eichenfield, Haixin Zhang, Debra Sierka, Faisal A. Khokhar, Artero Guillermo, Arsalan Shabbir, Siv Strömquist, Sonya Cyr	2022	14
12	Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials Dermatology and Therapy ·C.E.M. Griffiths, Marjolein de Bruin‐Weller, Mette Deleuran, Maria Concetta Fargnoli, D. Staumont‐Sallé, Chih-ho Hong, S.V. Borodin, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya Cyr, Ana B. Rossi	2021	21
13	Hospital Cost of Staphylococcal Infection after Cardiothoracic or Orthopedic Operations in France: A Retrospective Database Analysis Surgical Infections ·Aurélie Schmidt, Stève Bénard, Sonya Cyr	2015	24
14	TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model Vaccine ·Sonya Cyr, 正久保, Loïc Guillot, Xue-Ming Leng, Michael Crescent, Salman T. Qureshi, David S. Burt, Brian J. Ward	2008	33
15	TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces Vaccine ·Sophie Chabot, Christopher Molvar, M. Shawi, Jessica Wagner, Wang Tong-yan, David S. Burt, Sonya Cyr, Marian R. Neutra	2007	37
16	Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology Vaccine ·Sonya Cyr, Taff Jones, Xue-Ming Leng, Yang Nie, Sophie Chabot, K. Jury, David S. Burt, Brian J. Ward	2007	21
17	C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine Vaccine ·Sonya Cyr, Taff Jones, Xue-Ming Leng, David S. Burt, Brian J. Ward	2007	24
18	Intranasal Protollin™/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection Vaccine ·A. M. KUETHE, Jeffrey J. Adamovicz, Sonya Cyr, C R Bolt, 貞一高橋, M. Louise M. Pitt, George H. Lowell, David S. Burt	2005	46
19	A novel intranasal Protollin™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice Vaccine ·Sophie Chabot, Yang Nie, George H. Lowell, Martin Plante, Sonya Cyr, David S. Burt, Brian J. Ward	2004	40
20	Protollin™: a novel adjuvant for intranasal vaccines Vaccine ·Taff Jones, Sonya Cyr, Lucía Rivero, 貞一高橋, George H. Lowell, David S. Burt	2004	37

About Sonya Cyr

Sonya Cyr is a scholar working on Dermatology, Immunology and Allergy, Behavioral Neuroscience, Microbiology and Rheumatology, having authored 31 papers that have together received 494 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (18 papers), Food Allergy and Anaphylaxis Research (8 papers), Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (6 papers), Urticaria and Related Conditions (6 papers), Respiratory viral infections research (5 papers), Adrenal Hormones and Disorders (4 papers) and Influenza Virus Research Studies (3 papers). The work is most often cited by research in Immunology and Allergy (109 citations), Dermatology (129 citations), Immunology (172 citations), Microbiology (38 citations) and Endocrinology (24 citations). Sonya Cyr has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David S. Burt, George H. Lowell, Taff Jones, Brian J. Ward, Sophie Chabot, Martin Plante, Robert A. McDonald, Kazuhiko Arima, El‐Bdaoui Haddad and Aurélie Schmidt. Their work appears in journals such as Vaccine, Journal of Allergy and Clinical Immunology, Dermatology and Therapy, Pediatric Dermatology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact